They would love to discuss each and every one of your concerns mentioned. Have you contacted them?? ir@medoliferx.com They will happily discuss all of your concerns … reach out …
As for the ibuprofen… talk to them then you’ll gain understanding why not licensing .. I highly suggest folks reach out to them directly. Ask the questions and make notes … they are working on getting a CC put together soon .. they are wanting to hear from investors and welcome the questions So many things are being misconstrued and distorted .. really truly, I suggest contacting them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.